Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : APX-115
CAS No.: 1395946-75-4
Catalog No.: PC-60410Not For Human Use, Lab Use Only.
Isuzinaxib (APX-115, Ewha 18278) is a first-in-class, orally active, pan-NADPH oxidase (Nox) inhibitor with Ki of 1.08, 0.57, 0.63 nM for Nox1, Nox2, and Nox4, respectively.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 10 mg | $188 | In stock | |
| 25 mg | $328 | In stock | |
| 50 mg | $528 | In stock | |
| 100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Isuzinaxib (APX-115, Ewha 18278) is a first-in-class, orally active, pan-NADPH oxidase (Nox) inhibitor with Ki of 1.08, 0.57, 0.63 nM for Nox1, Nox2, and Nox4, respectively.
Isuzinaxib (APX-115) shows no inhibitory activities on xanthine oxidase and glucose oxidase.
Isuzinaxib (APX-115) inhibits the responses of BMMs to RANKL, including ROS generation, activation of MAPK and NF-κB, and osteoclast cells differentiation.
Isuzinaxib (APX-115) protects db/db mice from renal injury.
| M.Wt | 315.801 | |
| Formula | C17H18ClN3O | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride |
|
1. Cha JJ, et al. Lab Invest. 2017 Apr;97(4):419-431.
2. Kwon G, et al. Oncotarget. 2017 Jun 16. doi: 10.18632/oncotarget.18540.
3. Joo JH, et al. Sci Rep. 2016 Mar 15;6:22389.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
